{"transactions":[{"id":2880994,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":143108,"kind":"person","name":"GOLDBERG MORTON","position":1,"cik":"0001619731","reported_name":"GOLDBERG MORTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-04T02:51:44.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on February 1, 2022."}],"balance_after":3333,"derivative":{"exercise_price":6.46,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001104659-21-011845","document":"tm215262-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465921011845/tm215262-3_4seq1.xml","form_type":"4"}},{"id":3262314,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":143108,"kind":"person","name":"GOLDBERG MORTON","position":1,"cik":"0001619731","reported_name":"GOLDBERG MORTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-02-19T21:31:32.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":3333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Plan. The Option will become fully exercisable on February 1, 2021."}],"balance_after":3333,"derivative":{"exercise_price":6.55,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":3333},"source":{"system":"sec-edgar","filing":"0001104659-20-022844","document":"tm209305-4_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465920022844/tm209305-4_4.xml","form_type":"4"}},{"id":3349434,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":143108,"kind":"person","name":"GOLDBERG MORTON","position":1,"cik":"0001619731","reported_name":"GOLDBERG MORTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-06T23:45:15.000Z","date":"2019-12-06","kind":"sale","acquired":false,"shares":1961,"price":6.93,"value":13589.73,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-19-070723","document":"tm1924718-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465919070723/tm1924718-1_4.xml","form_type":"4"}},{"id":3372605,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":143108,"kind":"person","name":"GOLDBERG MORTON","position":1,"cik":"0001619731","reported_name":"GOLDBERG MORTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-13T21:18:52.000Z","date":"2019-11-12","kind":"sale","acquired":false,"shares":2001,"price":4.29,"value":8584.29,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective as of 08/30/2019, the Issuer effected a 1-for-15 reverse split of its common stock. The number of shares reflects the reverse stock split."}],"balance_after":1961,"source":{"system":"sec-edgar","filing":"0001104659-19-063335","document":"tm1922769-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000110465919063335/tm1922769-1_4.xml","form_type":"4"}},{"id":3673732,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":143108,"kind":"person","name":"GOLDBERG MORTON","position":1,"cik":"0001619731","reported_name":"GOLDBERG MORTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-02-05T21:38:52.000Z","date":"2019-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to 100% of the shares underlying the Option on February 1, 2020."}],"balance_after":50000,"derivative":{"exercise_price":0.48,"expiration_date":"2029-02-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001144204-19-005049","document":"tv512447_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420419005049/tv512447_form4.xml","form_type":"4"}},{"id":3868485,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":143108,"kind":"person","name":"GOLDBERG MORTON","position":1,"cik":"0001619731","reported_name":"GOLDBERG MORTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-12T20:57:23.000Z","date":"2018-07-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The restrictions will vest as to all of the shares on July 10, 2019."}],"balance_after":59441,"source":{"system":"sec-edgar","filing":"0001144204-18-038187","document":"tv498478_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420418038187/tv498478_4.xml","form_type":"4"}},{"id":4274298,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":143108,"kind":"person","name":"GOLDBERG MORTON","position":1,"cik":"0001619731","reported_name":"GOLDBERG MORTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-22T20:17:14.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to 100% of the shares underlying the Option on June 21, 2018."}],"balance_after":15000,"derivative":{"exercise_price":1.35,"expiration_date":"2027-06-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001144204-17-033618","document":"v469450_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417033618/v469450_4.xml","form_type":"4"}},{"id":4399899,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":143108,"kind":"person","name":"GOLDBERG MORTON","position":1,"cik":"0001619731","reported_name":"GOLDBERG MORTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-06T21:05:41.000Z","date":"2017-03-06","kind":"sale","acquired":false,"shares":8919,"price":3,"value":26757.0,"ownership":{"direct":true},"balance_after":9441,"source":{"system":"sec-edgar","filing":"0001144204-17-012941","document":"v461231_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417012941/v461231_4.xml","form_type":"4"}},{"id":4413355,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":143108,"kind":"person","name":"GOLDBERG MORTON","position":1,"cik":"0001619731","reported_name":"GOLDBERG MORTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-03-01T22:24:15.000Z","date":"2017-02-27","kind":"exercise","acquired":false,"shares":1083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted an option to purchase these shares pursuant to the Issuer's 2014 Equity Incentive Plan.  The option became exercisable as to 33% of the shares underlying the option on January 25, 2017, with 2.78% of the shares underlying the option vesting monthly thereafter."}],"balance_after":1917,"derivative":{"exercise_price":1.7,"expiration_date":"2026-01-25","underlying":"Common Stock","underlying_shares":1083},"source":{"system":"sec-edgar","filing":"0001144204-17-012195","document":"v460895_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417012195/v460895_4.xml","form_type":"4"}},{"id":4413354,"issuer":{"id":7940,"kind":"organization","name":"KIORA PHARMACEUTICALS INC","symbol":"KPRX"},"owners":[{"id":143108,"kind":"person","name":"GOLDBERG MORTON","position":1,"cik":"0001619731","reported_name":"GOLDBERG MORTON","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-01T22:24:15.000Z","date":"2017-02-27","kind":"exercise","acquired":true,"shares":1083,"price":1.7,"value":1841.1,"ownership":{"direct":true},"balance_after":18360,"source":{"system":"sec-edgar","filing":"0001144204-17-012195","document":"v460895_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372514/000114420417012195/v460895_4.xml","form_type":"4"}}]}